BPG is committed to discovery and dissemination of knowledge
Clinical Trials Study
Copyright: ©Author(s) 2026.
World J Gastrointest Endosc. Jun 16, 2026; 18(6): 117353
Published online Jun 16, 2026. doi: 10.4253/wjge.v18.i6.117353
Table 2 Comparison of other outcomes among the three protocols, n (%)/mean ± SD
Variable
Protocol 1 (1 L of PEG)
Protocol 2 (1 L of PEG and ascorbic acid)
Protocol 3 (1 L of water)
P value
Small bowel transit time (minutes)207 ± 13201 ± 14242 ± 140.086
Small Bowel CLEansing Assessment and Report (points)7.6 ± 0.27.9 ± 0.17.6 ± 0.20.236
First tertile2.5 ± 0.12.7 ± 0.12.7 ± 0.10.165
Second tertile2.6 ± 0.12.7 ± 0.12.6 ± 0.10.242
Third tertile2.5 ± 0.72.6 ± 0.62.3 ± 0.70.021
Diagnostic yield
First tertile12 (12.5)9 (9.7)12 (16.7)0.407
Second tertile9 (9.4)17 (18.3)8 (11.1)0.163
Third tertile34 (35.4)30 (32.5)26 (36.1)0.850
Ingestion of the entire booster81 (84.4)77 (82.8)68 (94.4)0.068
Tolerability, in a scale from 0 to 52.8 ± 0.13.0 ± 0.20.6 ± 0.1< 0.001


Write to the Help Desk